Our present results related to the DRN, together with previous reports on orexin’s role in EE and the interaction between the DRN and orexin neurons, reveal that targeting the orexin–DRN axis has the potential to attenuate disorders of energy balance and may provide a target for obesity and diabetes therapy. This evidence concerns the gene HCRT and obesity due to melanocortin 4 receptor deficiency.